Asahi Chemical Industry Co., Ltd. and
FMC Corporation announce that they have signed a mutual
agreement for the establishment of a joint venture company
in Hong Kong for the sale of pharmaceutical excipient
products of its parents.
The Joint Venture will sell pharmaceutical
excipients throughout Southeast Asia, China, Oceania,
excluding Japan. The Joint Venture will develop new
demand for pharmaceutical excipients by responding to
the need of pharmaceutical companies and by providing
high quality and quick service to customers with wide
range of products.
Asahi and FMC has been having a good
relationship in the pharmaceutical excipient business
since 1962. The establishment of the Joint Venture will
enhance the relationship of both companies.
Corporate Profile of New Joint Venture
| Name: |
Avicel Asia Pacific Limited |
| Capital: |
200 thousand US dollars |
| Shareholders: |
50%, Asahi Chemical |
| |
50%, FMC Hong Kong Limited |
| Headquarters: |
Hong Kong |
| Scheduled start-up: |
April 1, 1999 |
Corporate Profiles
Asahi Chemical Industry Co., Ltd. (as
of March 1998)
| Head Office: |
2-6, Dojimahama 1-chome, Kita-ku, Osaka |
| Paid-in Capital: |
¥103,400 million |
| No. of employees: |
about 27,000 |
| President: |
Kazumoto Yamamoto |
FMC Corporation (as of December 1997)
| Head Office: |
Chicago, U.S.A. |
| Paid-in Capital: |
US$144.8 million |
| No. of employees: |
about 17,000 |
| President: |
Larry D. Brady |
|
